EGFR and cancer: KEGG analyses showed that EC, pathways in cancer, the ERBB signaling pathway, the MAPK signaling pathway, the chemokine signaling pathway, the B cell receptor signaling pathway, endocytosis, cell cycles, mismatch repair, and leukocyte transendotheliat migration were significantly enriched in the high-risk group (Figure 9A, Table 1).